Drug class

Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)

Antidepressant serotonin-norepinephrine reuptake inhibitors (SNRIs) constitute a class of psychotropic medications primarily designed to treat mood and chronic pain disorders. Read more about Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)

127 drugs in this class 71 manufacturers

Advertisement

Drugs in Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)

Showing 46–54 of 127 drugs

DULOXETINE HCL

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+5
APHENA PHARMA S

DULOXETINE HCL

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+5
QUALITY CARE

DULOXETINE HCL

ANTIDEPRESSANTS · MAJOR DEPRESSIVE DISORDER ·+5
UNIT DOSE SERVI
Filter & compare in the drug finder → Opens the drug finder with Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs) preselected. Add indication or manufacturer filters there.

About Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs).

Antidepressant serotonin-norepinephrine reuptake inhibitors (SNRIs) constitute a class of psychotropic medications primarily designed to treat mood and chronic pain disorders.

They exert their therapeutic effect by inhibiting the presynaptic reuptake transporters for both serotonin and norepinephrine, thereby elevating the synaptic concentrations and neurotransmission of these monoamines in the central nervous system.

Clinically, members of this class are widely approved and indicated for major depressive disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder.

Additionally, due to their descending pain pathway modulation, certain SNRIs are established therapies for chronic pain syndromes, including fibromyalgia, diabetic peripheral neuropathic pain, and chronic musculoskeletal pain.